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The CD8aa homodimer is crucial to both thymic T cell selection and the antigen
recognition of cytotoxic T cells. The CD8-pMHC-I interaction can enhance CTL
immunity via stabilizing the TCR-pMHC-I interaction and optimizing the cross-reactivity
and Ag sensitivity of CD8+ T cells at various stages of development. To date, only human
and mouse CD8-pMHC-I complexes have been determined. Here, we resolved the
pBF2*1501 complex and the cCD8aa/pBF2*1501 and cCD8aa/pBF2*0401 complexes
in nonmammals for the first time. Remarkably, cCD8aa/pBF2*1501 and the cCD8aa/
pBF2*0401 complex both exhibited two binding modes, including an “antibody-like”
mode similar to that of the known mammal CD8/pMHC-I complexes and a “face-to-face”
mode that has been observed only in chickens to date. Compared to the “antibody-like”
mode, the “face-to-face” binding mode changes the binding orientation of the cCD8aa
homodimer to pMHC-I, which might facilitate abundant gdT cells to bind diverse peptides
presented by limited BF2 alleles in chicken. Moreover, the forces involving in the
interaction of cCD8aa/pBF2*1501 and the cCD8aa/pBF2*0401 are different in this two
binding model, which might change the strength of the CD8-pMHC-I interaction,
amplifying T cell cross-reactivity in chickens. The coreceptor CD8aa of TCR has
evolved two peptide-MHC-I binding patterns in chickens, which might enhance the T
cell response to major or emerging pathogens, including chicken-derived pathogens that
are relevant to human health, such as high-pathogenicity influenza viruses.
Keywords: chicken gdT cells response, CD8/pMHC-I interaction, face-to-face mode, cCD8aa/pBF2*1501,
cCD8aa/pBF2*0401org November 2020 | Volume 11 | Article 6050851
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Critical molecules involved in immune defense can be subject to
an evolving molecular arms race with all kinds of pathogens, of
which the most famous has led to the multiple loci, high allelic
polymorphism and high sequence diversity of major
histocompatibility complex (MHC) genes (1). These genes
encode the classical class I and class II (aka MHC-I/II)
molecules that bind antigenic peptides and present them for
recognition by the T cell receptor (TCR) on T lymphocytes
bearing coreceptors CD8 and CD4, respectively (2). TCR and
CD8 cooperatively bind to the peptide-MHC-I complex (aka
CD8-pMHC-I), which amplifies the peptide discrimination (3).
The CD8-pMHC-I interaction enhances cytotoxic T lymphocyte
immunity (4, 5) via stabilizing the TCR-pMHC-I interaction (6),
recruiting essential signaling molecules to the intracellular side of
the TCR-CD3 complex and locating the TCR to specific
membrane domains at the cell surface (7–11). Over one
million different peptides could be presented by a single
classical MHC class I molecule and recognized by a single TCR
via T cell cross-reactivity, a crucially important phenomenon in
immune surveillance (12, 13). In addition, the CD8-pMHC-I
interaction extends the range of pMHC-I ligands and is
necessary to control the optimal T cell cross-reactivity (14).
Indeed, an enhanced level of T cell cross-reactivity in mice was
predicted on theoretical grounds (13) because of stronger CD8-
pMHC-I interaction than in humans. However, the multiple
structural basis of T cell cross-reactivity has now been explained,
focusing on the interaction between TCR and pMHC-I and the
characteristics of peptide binding (15).
In representative mammals such as humans and mice, only
two nonpolymorphic CD8 genes are found, CD8A and CD8B
(16). The CD8 dimer exists as a glycoprotein on the T cell surface
in two isoforms, CD8aa and CD8ab. According to current
knowledge of human and mouse immunology, CD8a is mainly
expressed on the surface of gdT cells, natural killer (NK) cells and
dendritic cells (DCs) (17). Despite the different isoforms, CD8aa
and CD8ab show similar affinity for pMHC-I, and both CD8aa
and CD8ab interact with pMHC-I and promote TCR-pMHC-I
recognition (18, 19). The chicken is the best-characterized
nonmammal model in terms of immunology (20). Both
chicken CD8ab and CD8aa dimers are found on similar cells
to those in mammals (21–24). In comparison with the known
human and mouse CD8a proteins, chicken CD8a (cCD8a)
showed lower diversity in the CDR1-like loop and the CDR2-
like loop caused by mutation of their specific amino acid
sequences (25, 26). In addition, cCD8aa maintains a few
conserved residues with respect to the interaction of human
and mouse CD8aa with pMHC-I (26). In contrast to the lower
gd T cell numbers in human and mouse (27, 28), CD8+gdT cells
represent a major cytotoxic lymphocyte (CTL) subset appearing
in the peripheral blood as well as organs such as the gut, spleen,
thymus, and bursa of Fabricius of chicken (29–31), constituting
up to 50% of peripheral T cells (32, 33). Indeed, after pathogenic
bacteria infection, CD8aa+ gd T cell subsets in the spleen,
caecum and blood were expanded, further performing CTL
immunobiological function (34).Frontiers in Immunology | www.frontiersin.org 2To date, only human and mouse CD8-pMHC-I interactions
have been determined; that is, the structures of hCD8aa/HLA-
A*0201, hCD8aa/HLA-A*2402, mCD8aa/H-2Kb and
mCD8ab/H-2Dd have been resolved (19, 35–37). These CD8/
pMHC-I structures reveal that CD8 binds to the protruding
pMHC-I a3 domain CD loop in an antibody-like manner.
Human and mouse CD8 interact with pMHC-I in an allele-
dependent but TCR- and peptide-independent manner (38, 39).
However, CD8 engagement guides the geometry of TCR-pMHC-
I recognition to achieve the intracellular juxtaposition of
coreceptor-bound Lck with CD3 ITAMs (34, 40). However, to
date, there is still a lack of information on the nonmammalian
CD8/pMHC-I complex structure.
In the first comparative analysis, only two residues on the
surface of the chicken class I a3 domain were found to be
identical with those in mammals, which led to a proposal for the
contact site for CD8 binding (41), now amply confirmed by
mutagenesis, structural analysis and biophysical analysis in
humans and mice (35–37, 42–44). In addition, the chicken
class I a3 domain displays moderate levels of allelic
polymorphism and sequence diversity (25, 45), suggesting a
complementary selective pressure for diversity in the ligand for
the polymorphic and polygenic chicken CD8A system. Of further
interest is the fact that only the classical class I gene BF2 is
expressed at a high level in chickens, and chickens can live or die
based on whether pathogen peptides are bound and presented by
the dominantly expressed class I molecule (46–48), intensifying
the selection for appropriate CD8 binding.
In this paper, we determined amazingly high affinities
between chicken CD8aa homodimers and pBF2*1501
compared to mammalian CD8-pMHC-I interactions and
derived cocrystals of chicken CD8aa homodimers with
pBF2*1501 and pBF2*0401. We first confirmed that CD8
dimers recognize the same CD loop of the a3 domain in two
different modes, namely, an “antibody-like”mode and a “face-to-
face” mode that does not occur in mammals. The two binding
models are very helpful to the understanding of chicken T cell
immunity, including the limited MHC-I allelic genes and added
specific T cell constituents. In addition, the two binding modes
may have developed due to the molecular arms race with major
or emerging pathogens, including chicken-derived pathogens
that are relevant to human health, such as highly variable and
highly pathogenic influenza virus strains.MATERIALS AND METHODS
Protein Preparation
The peptide RY0808 (RRREQTDY) derived from MDV was
synthesized by Invitrogen, USA. The pET21a plasmids encoding
chicken CD8a, BF2*1501, BF2*0401, and b2m and another
peptide termed IE8 (IDWFDGKE) for prokaryotic expression
were maintained in our laboratory (26, 49, 50). Proteins of
chicken CD8a (cCD8a), BF2*1501, BF2*0401, and b2m were
expressed as inclusion bodies, and the preparation of soluble
cCD8a protein was carried out essentially as described
previously (26). The cCD8aa protein was purified on aNovember 2020 | Volume 11 | Article 605085
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after the refolding of BF2*1501 and b2m with RY0808 and of
BF2*0401 and b2m with the IE8 peptide, the refolded complexes
were further purified on a Superdex 200 16/60 column, followed
by Resource Q anion-exchange chromatography (GE Healthcare,
USA). The purified RY0808-BF2*1501-b2m (pBF2*1501) and
IE8-BF2*0401-b2m (pBF2*0401) complexes were buffer-
exchanged three times with 10 mM Tris-HCl, 50 mM NaCl,
pH 8.0. Next, pBF2*1501, the cCD8aa and pBF2*1501
(cCD8aa/pBF2*1501) complexes and the cCD8aa and
pBF2*0401 complexes (cCD8aa/pBF2*0401) were mixed at a
2:1 molar ratio at 277 K overnight. Finally, the chicken protein
complexes pBF2*1501, cCD8aa/pBF2*1501, and cCD8aa/
pBF2*0401 were diluted to 5 mg ml-1 and 10 mg ml-1.
Affinity Analysis by Surface Plasmon
Resonance and Superdex75 16/60 Column
Surface plasmon resonance binding experiments were performed
on a Biacore3000. pBF2*1501 and cCD8aa protein both were
purified with buffer containing 10mM HEPES PH 7.4, 150mM
NaCl, 3mM EDTA and 0.005% Tween 20. pBF2*1501 was
covalently coupled with CM-5 chip (cat. no. BR-1000-14,
Biacore-GE Healthcare, Piscataway, NJ) as the stationary
phase. The different concentration of cCD8aa including 0,
0.78, 1.56, 3.125, 6.25, 12.5, 25, and 50 mM were injected as the
mobile phase. And then, the data were analyzed with BIA
Evaluation Software 3.2. The coupling conditions and data
analysis were performed as described previously (51). After the
incubation of purified cCD8aa and pBF2*1501 for 3 h at 4°C,
the coexistence of chicken cCD8aa and pBF2*1501 complexes
on the gel column was tested by using a Superdex 75 16/60
column (GE Healthcare, USA) and sodium dodecyl sulfate-
polyacrylamide gel electrophoresis (SDS-PAGE).
Crystallization and Data Collection
The complexes pBF2*1501, cCD8aa/pBF2*1501 and cCD8aa/
pBF2*0401were screened in crystallization trials by the sitting-drop
vapor-diffusion method with the Index, Crystal Screen, Crystal
Screen 2,Crystal ScreenCryo, Crystal Screen 2Cryo, andPEG Ion 1
and 2 Kits (Hampton Research, USA) at 291 K. Crystals from the
protein concentration of 10 mg ml-1 were observed in PEG Ion Kit
No. 16 (0.2 M magnesium nitrate hexahydrate, 20% (w/v)
polyethylene glycol 3,350, pH 5.8) and Index Kit No. 72 (0.2 M
sodium chloride, 25% (w/v) polyethylene glycol 3,350, 0.1 M
HEPES pH 7.5) and No. 67 (0.2 M ammonium sulfate, 0.1 M Bis-
tris pH 6.5, 25% (w/v) polyethylene glycol 3,350). Diffraction data
from chicken pBF2*1501, cCD8aa/pBF2*1501 and cCD8aa/
pBF2*0401 complexes were collected on Beamline BL17U at the
Shanghai SynchrotronRadiation Facility (SSRF; Shanghai, People’s
Republic of China) at a wavelength of 0.97972 Å with an ADSC
Q315 CCD detector. The collected diffraction data were indexed
and scaled with HKL2000 (52).
Structure Determination and Refinement
The structures were determined by molecular replacement by
using Molrep and Phaser in the CCP4 package, with the
structures of chicken CD8aa [Protein Data Bank (PDB) code:Frontiers in Immunology | www.frontiersin.org 35EB9] and BF2*0401-IE8 [PDB code: 4E0R] as the search
models. The construction and refinement of the complex were
performed by the programs Coot and Refmac5. Subsequent
refinements were conducted for energy minimization, the
restriction of individual B factors, and the addition of water
molecules, with noncrystallographic symmetry restraints applied
to the one molecule of pBF2*1501 and the two molecules of
chicken cCD8aa/pBF2*1501 and cCD8aa/pBF2*0401 in the
asymmetric unit. Ramachandran plots and secondary structure
assignments were generated by SFCHECK (53). The final
structures of the complex consisted of pBF2*1501 and two
complete chicken cCD8aa/pBF2*1501 and cCD8aa/
pBF2*0401 molecules, with R-factor = 0.2304, R-free = 0.2647;
R-factor = 0.2533, R-free = 0.2990; and R-factor = 0.2519,
R-free = 0.2881, respectively. These crystal structures of
cCD8aa/pBF2*1501, cCD8aa/pBF2*0401, and pBF2*1501
have been deposited in the PDB (http://www.pdb.org/pdb/
home/home.do) with accession numbers 6LHF, 6LHG
and 6LHH.
Structural Analysis and Generation of
Illustrations
The residues involved in the interactions of cCD8aa with
pBF2*1501 and pBF2*0401 were identified by the web servers
PDBePISA (https://www.ebi.ac.uk/pdbe/pisa/) (13) and Ring
(http://protein.bio.unipd.it/ring/) (12). Structural illustrations
and electrostatic potential surfaces were generated with the
PyMOL molecular graphics system (DeLano Scientific; http://
www.pymol.org).RESULTS
An Unexpected Interaction Exists Between
cCD8aa and pBF2*1501
The affinity between cCD8aa and pBF2*1501 (Kd=3.8 mM) is
higher than the known binding of CD8 and pMHC-I in
mammals (54) (Figures 1A, B). Additionally, cCD8aa and
pBF2*1501 can stably coexist on a gel column in vitro (Figure
1C). In addition, the amino acids of chicken BF2 molecules
exhibited a large difference from those of humans and mice,
especially for the a3 domain, and only 28 conserved residues
exist between the a3 domains of BF2 molecules and HLA-
A*0201 and mouse H-2Kb (Figure 2A). In addition, there were
only 20 conserved residues between chicken CD8a and human
and mouse CD8a (Figure 2B). Therefore, an unexpected
interaction between chicken CD8a and pMHC-I was distinct
from those in humans and mice.
To investigate the interaction of CD8 and classical class I
molecules in chickens, cocrystals of pBF2*1501 with peptide
RRREQTDY (RY0808), of cCD8aa homodimers with the
pBF2*0401 molecule and the peptide IDWFDGKE (IE8) were
formed as previously reported (49), as well as cCD8aa
homodimers with the pBF2*1501 molecule just described,
which diffracted to 2.7 Å, 2.6 Å, and 2.8 Å and belonged to the
P3121, P1, and P21 space groups, respectively (Table 1).November 2020 | Volume 11 | Article 605085
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FIGURE 1 | Affinity measurement by surface plasmon resonance (SPR) and gel column coexistence testing of cCD8aa/pBF2*1501 complex in vitro. (A) pBF2*1501
was the stationary phase, and cCD8aa diluted to 0, 0.78, 1.56, 3.125, 6.25, 12.5, 25, and 50 mM was the mobile phase. (B) The affinity was measured to be
Kd=3.8 mM. (C) Purification peak map of cCD8aa, pBF2*1501 and cCD8aa/pBF2*1501, which are colored gray, light blue and pink. The peak position of cCD8aa/
pBF2*1501 is in front of that of pBF2*1501, and SDS-PAGE identification of the cCD8aa/pBF2*1501 complex peak shows three distinct bands corresponding to
BF2*1501, b2m, and cCD8a protein.A
B
FIGURE 2 | Multiple amino-acid sequence alignments. (A) Multiple amino-acid sequence alignment of BF2*1501, BF2*0401, BF2*2101, HLA-A*0201, HLA-A*2402,
and H-2Kb mature peptides. The a1, a2, and a3 domains of pMHC-I molecules are shown by three lines. The secondary structure and sequence number are
marked above the sequence alignment. (B) Multiple alignment of chicken, human and mouse CD8a mature peptides. The secondary structure and sequence
number are marked above the sequence alignment.Frontiers in Immunology | www.frontiersin.org November 2020 | Volume 11 | Article 6050854
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Loop of pMHC-I
The BF2*1501 complex consists of a1, a2, a3 domains of the
heavy chain, a light chain cb2m, and the 8-mer peptide
RRREQTDY (henceforth called RY0808), which is extremely
similar to other known chicken class I molecules including
BF2*2101 (3BEV), BF2*0401 (40ER), BF2*1401 (4CW1),
BF2*1201 (5YMV) with Ca root mean square deviations
(RMSDs) value of 0.83 Å, 0.54 Å, 0.51 Å and 0.82 Å
respectively; the complexes also share the closely similar a3
domain CD loop (Figure 3A). However, the chicken BF2
structures differ more from human, mouse, bovine, and swine
MHC class I structures, with Ca RMSD values of 2.61 Å, 2.11 Å,
1.98 Å, and 1.91 Å, especially for the a3 domain CD loops, which
are shifted away from the human and mouse CD8 orientation by
approximately 3.4-3.7 Å, which theoretically should result in a
spatial relationship between cCD8 and the a3 domain of pMHC-
I in chickens (Figure 3B). This different conformation of the a3
domain CD loop might lead to the distinct binding mode
between CD8 and pMHC-I complexes in chickens and
mammals because of the narrow space for CD8 engagement
in chickens.
Similar to the human hCD8aa/pHLA-A*2402 and mouse
mCD8aa/pH-2Kb complexes, each unit cell of cCD8aa/
pBF2*1501 and cCD8aa /pBF2*0401 contained two
asymmetric complexes, each with one class I heterotrimer
(RY0808/BF2*1501/b2m and IE8/BF2*0401/b2m) and oneFrontiers in Immunology | www.frontiersin.org 5CD8aa homodimer, termed complex A and complex B
(Figure 4). In addition, cCD8aa binding did not change the
main chain of the peptides, except that some side chains of
the nonanchoring peptide residues became flexible in both the
cCD8aa/pBF2*0401 and cCD8aa/pBF2*1501 complexes, which
did not alter the peptide binding to BF2*1501, BF2*0401 and the
corresponding TCR (Figures 3C and S1A). However, compared
to the pBF2*1501 complex, the a3 domain CD loop of complex
A and complex B with intact mesh were pulled towards cCD8aa
by approximately 4.2 Å and 3.8 Å in the cCD8aa/pBF2*1501
complex. Complexes A and B of cCD8aa/pBF2*0401 also
moved towards cCD8aa by approximately 4.3 Å and 4.0 Å
(Figures 3C and S1B). Moreover, the crucial protruding a3
domain CD loop differs in direction, and the protruding loop
(220~228) in the CD loop of the a3 domain is an important
region for CD8 binding independent of species (43, 55, 56)
(Figure 3C). This phenomenon is completely different from the
“pull” and “push” binding of the MHC-I a3 domain CD loop
adopted by complexes A and B, respectively, in humans and mice
(35, 36).
Chicken cCD8aa/pMHC-I Complexes
Demonstrate Two Different cCD8aa
Engagement Modes
The CD loop of complex B lies closer to the cCD8aa
homodimer, and the whole cCD8aa homodimer clearly skews
towards the a2 domain and b2m in complex A compared to
complex B (Figure 5). The hCD8aa/pHLA-A*0201, hCD8aa/
pHLA-A*2402 and mCD8aa/pH-2Kb complexes proved that
the CD loop of a3 domain forms hydrogen bonds and salt
bridges with CD8aa. The a3 domain CD loop is clamped by all
six CDR-like loops of CD8aa, among which Gln226 is the most
important residue and is conserved across different species.
In cCD8aa/pBF2*1501 complex A, the corresponding residue
Gln222 only forms two hydrogen bonds with Asn102 on F strand
and Gln105 on CDR3-like loop of the cCD8a1 subunit and forms
one hydrogen bond with Asn102 on F strand of the cCD8a2
subunit instead of the conserved C strand that located on the deep
of CD8 cavity in humans and mice. Moreover, Ala224 of a3
domain CD loop forms one hydrogen bond with Gln105 of the
cCD8a1 CDR3-like loop, and Asp223 of a3 domain CD loop
forms one hydrogen bond with Tyr54 of the cCD8a2 C′ strand in
complex A (Figure 5A). Besides that, four water molecules
participate in the interactions and forms a forces network
between a3 domain CD loop and cCD8a subunits (Figure 5A).
In cCD8aa/pBF2*0401 complex A, the corresponding residue
Gln222 only forms onehydrogen bondwithGln105 onCDR3-like
loop of the cCD8a1 subunit. Another two hydrogen bonds are
formed between Val219 and Ser226 of a3 domain CD loop and
Asn104of the cCD8aaCDR3-like loop, andAsp223ofa3domain
CD loop forms one hydrogen bond with Tyr54 of the cCD8a2 C′
strand in complex A (Figure 5B). Therefore, Gln222 of BF2*1501
and BF2*0401 a3 domain CD loops is not a significant residue,
which inserts into the deep of CD8 cavity and contribute to the
antibody-like interactionmodel existing in the human andmouse
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residue contributing to the antibody-like binding model of the
mammalian CD8aa/pMHC-I complex (35–37). The special
interaction contributed by important residue Gln222 and other
distinct interactions between cCD8aa and the CD loop of the a3
domain leads to the rotation of complex A towards thea2 domain
andb2m in comparison to complexB,whichfinally creates a novel
binding mode that we termed the “face-to-face” mode (Figure 5
and Table 2).Frontiers in Immunology | www.frontiersin.org 6However, cCD8aa/pBF2*1501 complex B and cCD8aa/
pBF2*0401 complex B present a parallel binding model of
cCD8aa interaction with hCD8aa/pHLA-A*0201 and
mCD8aa/pH-2Kb. In the CD loop of the pBF2*1501 a3
domain, Ser226 forms one hydrogen bond with Asn104 of the
CDR3-like loop of cCD8a1 subunit; Gln225 forms two hydrogen
bonds with Asn104 of the CDR3-like loop of cCD8a1 subunit;
Asp223 forms one hydrogen bond with Tyr54 of the cCD8a2 C′
strand; Val219 forms two hydrogen bonds with Asn104 of theA B
C
FIGURE 3 | Superposition of pBF2*1501 with other known chicken pMHC-I structures, representative mammal pMHC-I structures and cCD8aa/pBF2*1501 and
cCD8aa/pBF2*0401 complexes. (A) Superimposed Ca traces of chicken BF2*1501-RY0808-b2m (green), pBF2*0401 (PDB code: 4E0R, cyan), pBF2*2101 (PDB
code: 3BEV, light blue), pBF2*1401 (PDB code: 4CW1, purple), and pBF2*1201 (PDB code: 5YMV, brown). (B) Ca-trace comparison of BF2*1501-RY0808-b2m
(green), HLA-A*0201 (PDB code: 1HHK, cyan), H-2Kb (PDB code: 1G7Q, blue), SLA-1*0401 (PDB code: 3QQ3, light purple), and BoLA-N*01801 (PDB code:
3PWU, light red), with an enlarged view of the CD loop in the gray box. (C) Overlap between free pBF2*1501 and pBF2*1501 of cCD8aa/pBF2*1501 and between
free pBF2*0401 and pBF2*0401 of cCD8aa/pBF2*0401, based on the a1 and a2 domains, respectively. Enlarged views of the overlapped peptides are shown in
the dotted red box and dotted orange box for cCD8aa/pBF2*1501 and cCD8aa/pBF2*0401, respectively; an enlarged view of the overlapped a3 domain CD loop
is shown in the red box and orange box for cCD8aa/pBF2*1501 and cCD8aa/pBF2*0401. Free pBF2*1501, pBF2*1501 of cCD8aa/pBF2*1501 complex A,
pBF2*1501 of cCD8aa/pBF2*1501 complex B, free pBF2*0401, pBF2*0401 of cCD8aa/pBF2*0401 complex A and pBF2*0401 of cCD8aa/pBF2*0401 complex B
are colored green, yellow, light pink, cyan, orange, and light blue, respectively.November 2020 | Volume 11 | Article 605085
Liu et al. Chicken CD8/pMHC I ComplexcCD8a2 CDR3-like loop, and the important residue Gln222
forms one hydrogen bond with Ser39 of the cCD8a2 C strand
and a water molecule participates in the stabilization of Gln222
(Figure 5A). In the pBF2*0401 a3 domain CD loop, in addition
to two hydrogen bonds formed by Val219 with Asn104 of
cCD8a2, the Arg220 forms one hydrogen bond with Asp35 of
cCD8a2 CDR1-like loop, the Asp223 forms one hydrogen bond
with Tyr54 of the cCD8a2 C′ strand, the Ser226 forms one
hydrogen bond with Asn104 of the cCD8a1 CDR3-like loop, and
the protruding residue of Gln222 forms two hydrogen bonds
with Ser39 of the cCD8a2 C strand (Figure 5B). Thus, the two
cCD8a subunits clamp the CD loop, and the key residue Gln222
inserts into the deep of CD8 cavity and plays vital roles in theFrontiers in Immunology | www.frontiersin.org 7interactions of complexes B, which is similar to the classical
binding mode in mammalian CD8/pMHC-I complexes.
The “Face-to-Face” Mode Causes
Different and Fewer Interactions in
Complex A
In addition to those in the CD loop, other differences exist in the
a2, b2m and a3 domains of cCD8aa/pBF2*1501 and cCD8aa/
pBF2*0401 complexes A and B (Figure 6 and Supplementary
Table 1). In cCD8aa/pBF2*1501 complex A, Arg207 of the a3
domain BC loop forms one hydrogen bond and one salt bridge
with Asp35 of the cCD8a1 CDR-like loop (Figure 6A).
However, in cCD8aa/pBF2*1501 complex B, one hydrogenA
B
FIGURE 4 | Overall view of chicken cCD8aa/pBF2*1501 and cCD8aa/pBF2*0401 complexes. (A) An asymmetric unit contains two chicken cCD8aa/pBF2*1501
complexes, namely, complex A and complex B, each consisting of pBF2*1501 (BF2*1501, chicken b2m, and the peptide RY0808) and the cCD8aa homodimer.
pBF2*1501, the cCD8a1 subunit, and the cCD8a2 subunit of complex A are colored yellow, gray and blue, respectively. pBF2*1501, the cCD8a1 subunit, and the
cCD8a2 subunit of complex B are colored pink, light brown and orange, respectively. (B) An asymmetric unit contains two chicken cCD8aa/pBF2*0401 complexes,
namely, complex A and complex B, each consisting of pBF2*0401 (BF2*0401, chicken b2m, and the peptide IE8) and the cCD8aa homodimer. pBF2*0401, the
cCD8a1 subunit, and the cCD8a2 subunit of complex A are colored orange, gray and yellow, respectively. pBF2*0401, the cCD8a1 subunit, and the cCD8a2
subunit of complex B are colored blue, deep green, and pink, respectively.November 2020 | Volume 11 | Article 605085
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B
FIGURE 5 | Superposition of complex A and complex B of cCD8aa/pBF2*1501 and cCD8aa/pBF2*0401 using the Ca atoms of domains a1 and a2. (A) Overlap
of complex A and complex B of cCD8aa/pBF2*1501 based on the Ca atoms of domains a1 and a2, as shown from the front view and in a clockwise rotation by
90°. The interaction details between the a3 domain CD loop and the cCD8aa homodimer are shown in an enlarged view in yellow and pink boxes for complex A
and complex B, respectively. In complex A, the contact residues are shown in stick representation, and the residues of BF2*1501 are colored yellow. The residues of
cCD8a1 are colored gray, the residues of cCD8a2 are colored light blue, and the interaction forces are marked by black dotted lines. In complex B, the contact
residues are shown in stick representation, and the residues of BF2*1501 are colored light pink. The residues of cCD8a1 are colored light brown, the residues of
cCD8a2 are colored orange, and the interaction forces are marked by black dotted lines. pBF2*1501 of cCD8aa/pBF2*1501 complex A and cCD8aa/pBF2*1501
complex B are colored yellow and light pink; the cCD8a1 and cCD8a2 subunits of the cCD8aa/pBF2*1501 complex A are colored light gray and light blue; and the
cCD8a1 and cCD8a2 subunits of cCD8aa/pBF2*1501 complex B are colored light brown and orange. The yellow and pink rectangles represent the central plane of
the cCD8aa homodimer of complex A and complex B of cCD8aa/pBF2*1501, respectively. (B) Overlap of complex A and complex B of cCD8aa/pBF2*0401 based
on the Ca atoms of domains a1 and a2, shown from the front view and rotated clockwise by 90°. The interaction details between the a3 domain CD loop and the
cCD8aa homodimer are shown in enlarged views in light orange and light blue boxes for complex A and complex B, respectively. In complex A, the contact residues
are shown in stick representation, and the residues of BF2*0401 are colored light orange, the residues of cCD8a2 are colored yellow, and the interaction forces are
marked by black dotted lines. In complex B, the contact residues are shown in stick representation, the residues of BF2*0401 are colored light blue, the residues of
cCD8a1 are colored deep green, the residues of cCD8a2 are colored pink, and the interaction forces are marked by black dotted lines. pBF2*0401 of cCD8aa/
pBF2*0401 complex A and cCD8aa/pBF2*0401 complex B are colored light orange and light blue; the cCD8a1 and cCD8a2 subunits of cCD8aa/pBF2*0401
complex A are colored gray and yellow; and the cCD8a1 and cCD8a2 subunits of cCD8aa/pBF2*0401 complex B are colored deep-green and pink. The orange
and blue rectangles represent the central plane of the cCD8aa homodimer of complex A and complex B of cCD8aa/pBF2*0401, respectively.Frontiers in Immunology | www.frontiersin.org November 2020 | Volume 11 | Article 6050858
Liu et al. Chicken CD8/pMHC I Complexbond was formed between Arg207 and Asp35, and Glu258 forms
one salt bridge with Arg60 of cCD8a1, Lys215 forms one
hydrogen bond with Asp35 of cCD8a2 (Figure 6A). In the
cCD8aa/pBF2*0401 complex A, the corresponding residue
Arg207 of the a3 domain BC loop forms one hydrogen bond
and one salt bridge with Asp35 of the cCD8a1 CDR1-like loop,
and the corresponding residue Glu258 of the a3 domain E strand
forms one salt bridge with Arg60 of the cCD8a1 C′′ strand
(Figure 6B). In contrast, the corresponding residues Arg207
forms two hydrogen bonds with Asp35 of cCD8a1, and Glu244
forms one salt bridge with Arg60 of the cCD8a2 C′′ strand in
cCD8aa/pBF2*0401 complex B (Figure 6B).
In the a2 domain of cCD8aa/pBF2*1501 complex A, Asp104
of the b4-b5 loop forms one hydrogen bond with Gln78 of the
cCD8a1 DE loop, and Asp100 of the b4 strand contacts to Ser80
of the cCD8a1 DE loop with the help of water molecule (Figure
6A). However, in cCD8aa/pBF2*1501 complex B, Glu103 and
Asp104 of the b4-b5 loop form two hydrogen bonds with Gly79
and Gln78 of the cCD8a1 DE loop, and Asp124 of the b6-b7
loop forms one hydrogen bond with Arg14 of the cCD8a1 AB
loop (Figure 6A). In cCD8aa/pBF2*0401 complex A, the
residue Arg108 of the b5 strand forms one hydrogen bond
with Glu28 of the CD8a1 subunit B strand, Glu103 of the b4-
b5 loop forms two hydrogen bonds with Gln78 and Gly79 of the
cCD8a1 DE loop (Figure 6B). In contrast, the residue Glu103
and Asp104 of the b4-b5 loop form one hydrogen bond with
Gly79 and Gln78 of the cCD8a1 subunit DE loop respectively, in
cCD8aa/pBF2*0401 complex B (Figure 6B). In addition to
hydrogen bonds and salt bridges, six van der Waals contacts
are contributed by residues of BF2*1501 except for a3 CD loop
and eleven van der Waals contacts are contributed by b2m to the
interaction in cCD8aa/pBF2*1501 complex A (Supplementary
Table 1). In cCD8aa/pBF2*1501 complex B, twelve van der
Waals contacts formed by residues of BF2*1501 except for a3
CD loop and only five van der Waals contacts are contributed by
b2m (Supplementary Table 1). Besides forces contributed by the
a3 CD loop, other stable interactions, including hydrogen bonds,
salt bridges and van der Waals interactions, that assist in drawing
the pBF2*1501 and pBF2*0401 molecules close to cCD8aa are
also mostly different in complex A and complex B. Therefore, the
affinity should be different between cCD8aa and pBF2*1501 and
pBF2*0401 in complex A and complex B. In both cases, complex
B might possess a higher affinity between cCD8aa and
pBF2*1501 and pBF2*0401 than that of complex A, because
more forces including hydrogen bonds and van der Waals
interactions predominate between cCD8aa and pBF2*1501
and pBF2*0401 in complex B (Table 2). However, the solventsFrontiers in Immunology | www.frontiersin.org 9might influence the affinity between cCD8aa and pBF2*1501 in
complex A.Specific Interaction Features Between
cCD8 and pMHC-I Outside of Mammals
Complex B of cCD8aa/pBF2*1501 and complex B of cCD8aa/
pBF2*0401 share a similar CD8 interaction mode with
mammalian MHC-I, but the amino acids of BF2*1501 and
BF2*0401 especially for the a3 domain is different from
human and mouse pMHC-I molecules (Figure 2). Moreover,
the amino acid identity of CD8a is low in chicken, human and
mouse (Figure 2). These results reveal that chicken cCD8aa-
pMHC-I interaction represents a special feature differing from
humans and mice. Corresponding to sequence homology, the
interface forces among chicken, human and mouse CD8aa/
pMHC-I showed substantial differences (Figure 7). Only two
residues, Gln222 and Asp223 of BF2*1501, corresponding to
Gln226 and Asp227 in human and mouse MHC-I, and three
residues that participate in the complex interaction, Ser39, Tyr54
and Asn104 of cCD8a, are conserved between chicken and
mammals (Figures 7A, B).
In the case of hCD8aa/pHLA-A*0201, mutagenesis of any of
the three residues Gln115, Asp122 and Glu128 in the HLA-
A*0201 a2 domain can abolish hCD8aa binding (37). However,
three different residues, Glu103, Asp104 and Asp124, in the
BF2*1501 a2 domain form contacts with cCD8aa (Figure 7A).
Moreover, mutagenesis data on the a3 domain of the human and
mouse complexes showed that three clusters of a3 domain
residues (residues 220–232, 233–235, and 245–247) and
especially the MHC-I a3 CD loop (residues 220–228) are key
to the CD8aa-pMHC-I interaction (43, 56). However, in
chickens, in addition to Gln222 and Asp223, another five
nonconserved residues of BF2*1501, Arg207, Lys215, Val219,
Gln225, Ser226, and Glu258, are the main contributors to the
interaction with cCD8aa (Figures 7A, B). Among the seven
residues, five of them fall into the cluster 220-228, but two
residues, Val219 and Gln225, are specific to chickens.
Furthermore, Arg207 is located on the BC loop of the
BF2*1501 a3 domain, which is absent in the interactions
between CD8a and HLA-A*0201 and H-2Kb, and no residues
of the BC loop participate in the interaction in humans and mice.
Another three residues, Lys215, Ser226, and Glu258, are also
species specific, although the corresponding residues Glu229 and
Gln262 contribute to the interactions in mCD8aa/pH-2Kb and
hCD8aa/pHLA-A*0201, respectively.
Like the BF2*1501 molecules, most of the contact residues in
cCD8aa are chicken specific. For the cCD8a1 subunit, a total of
seven residues, namely, Gln78, Gly79, and Arg83 of the DE loop,
Arg14 of the AA’ loop, Asp35 of the CDR1 loop, Asn104, Gln105
of the CDR3 loop, contribute to the binding to BF2*1501 (Figure
7A). In addition to Asn104, six other residues are nonconserved
among chicken and human and mouse, and no corresponding
residues form contacts in hCD8a1 and mCD8a1 (Figures 7A
and S1B). However, three of four contact residues in the CD8a2
subunit are conserved among cCD8a and hCD8a and mCD8a,
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FIGURE 6 | Details of the interaction between the cCD8aa homodimer and pBF2*1501 and pBF2*0401 of complex A and complex B. (A) The interaction between
cCD8aa homodimer and the a1, a2, and a3 domains (exclusive of the CD loop) of pBF2*1501. The interactions of complex A are shown in enlarged views in yellow
boxes. The contact residues are marked by sticks and labeled by three-letter abbreviation and sequence number, and the interaction forces are marked by black
dotted lines. In complex A, the contact residues of pBF2*1501 are colored yellow, the contact residues of the cCD8a1 subunit are colored gray, and the contact
residues of the cCD8a2 subunit are colored blue. The interactions of complex B are shown in an enlarged view in a pink box. The contact residues are shown in
stick representation and labeled by three-letter abbreviation and sequence number, and the interaction forces are marked by the black dotted line. In complex A, the
contact residues of pBF2*1501 are colored pink, and the contact residues of the cCD8a1 subunit are colored light brown. (B) The interaction between the cCD8aa
homodimer and the a1, a2, and a3 domains (exclusive of the CD loop) of pBF2*0401. The interactions of complex A are shown in an enlarged view in an orange
box. The contact residues are shown in stick representation and labeled by three-letter abbreviation and sequence number, and the interaction forces are marked by
black dotted lines. In complex A, the contact residues of pBF2*0401 are colored orange, and the contact residues of the cCD8a1 subunit are colored gray. The
interactions of complex B are shown in an enlarged view in a pink box. The contact residues are shown in stick representation and labeled by three-letter
abbreviation and sequence number, and the interaction forces are marked by black dotted lines. The contact residues of pBF2*1501 are colored blue, the contact
residues of the cCD8a1 subunit are colored deep green, and the contact residues of the cCD8a2 subunit are colored pink.Frontiers in Immunology | www.frontiersin.org November 2020 | Volume 11 | Article 60508510
Liu et al. Chicken CD8/pMHC I ComplexTyr54 form contacts with Gln222, and these interactions are
conserved between chicken complex B and the mammalian CD8/
pMHC-I complex (Figures 7A, B). Another residue, Asp35, of
the CDR1 loop is completely species specific in chickens (Figures
7C and 2B).DISCUSSION
The immunemolecules of birds, represented by chickens, have low
amino acid homology to the corresponding human molecules, but
the topological structures of their protein complexes are similar.Frontiers in Immunology | www.frontiersin.org 11However, in essence, the 3D structures of chicken immune
molecules have their own species characteristics, which leads to
some differences in immunobiology. The current study
determined the structures of chicken CD8/pMHC-I complexes
for the first time, namely, cCD8aa/pBF2*1501 and cCD8aa/
pBF2*0401, which each contain complex A and complex B in an
asymmetrical unit. cCD8aa binds to pBF2*1501 and pBF2*0401
in an allele-dependent but peptide-independent manner, as
demonstrated by the CD8aa-pMHC-I interaction in previous
studies (38, 39). Remarkably, cCD8aa binds to pBF2*1501 and
pBF2*0401 in complex A of cCD8aa/pBF2*1501 and cCD8aa/
pBF2*0401 in a novel “face-to-face” mode, which is distinct fromA B C
FIGURE 7 | Contact residue conservation analysis among cCD8aa/pBF2*1501 complex B, cCD8aa/pBF2*0401 complex B, hCD8aa/pHLA-A*0201, mCD8aa/pH-
2Kb complexes. (A) Conservation analysis of contact residues between cCD8aa/pBF2*1501 complex B and the hCD8aa/pHLA-A*0201 complex. The alignment
between pBF2*1501 and pHLA-A*0201 is shown at the top, and the alignment between cCD8aa and hCD8aa is shown below. All contact residues are shown in
stick representation and labeled by three-letter abbreviation. The contact residues of pBF2*1501 and pHLA-A*0201 are colored pink and light brown, and the cyan
rectangle represents the a2 domain, while the pink rectangle represents the a3 domain. The contact residues of the cCD8a1 and cCD8a2 subunits are colored light
brown and orange, and the contact residues of the hCD8a1 subunit and hCD8a2 subunit are colored gray and brown. The light pink circle represents the CD8a1
subunit, and the light-blue circle represents the CD8a2 subunit. (B) Conservation analysis of contact residues between cCD8aa/pBF2*1501 complex B and the
mCD8aa/pH-2Kb complex. The alignment between pBF2*1501 and pH-2Kb is shown at the top, and the alignment between cCD8aa and mCD8aa is shown
below. All contact residues are shown in stick representation and labeled by three-letter abbreviation. The contact residues of pBF2*1501 and pH-2Kb are colored
pink and dark gray, and the cyan rectangle represents the a2 domain, while the pink rectangle represents the a3 domain. The contact residues of the cCD8a1
subunit and cCD8a2 subunit are colored light brown and orange, and the contact residues of the mCD8a1 subunit and mCD8a2 subunit are colored light red and
light pink. The light-pink circle represents the CD8a1 subunit, and the light-blue circle represents the CD8a2 subunit. (C) Conservation analysis of contact residues
between cCD8aa/pBF2*1501 complex B and cCD8aa/pBF2*0401 complex B. The alignment between pBF2*1501 and pBF2*0401 is shown at the top, and the
alignment of cCD8aa is shown below. All contact residues are shown in stick representation and labeled by three-letter abbreviation. The contact residues of
pBF2*1501 and pBF2*0401 are colored pink and blue, and the cyan rectangle represents the a2 domain, while the pink rectangle represents the a3 domain. The
contact residues of the cCD8a1 subunit and the cCD8a2 subunit of cCD8aa/pBF2*1501 complex B are colored light brown and orange, and the contact residues
of the cCD8a1 and cCD8a2 subunits of cCD8aa/pBF2*0401 complex B are colored deep green and pink. The light-pink circle represents the CD8a1 subunit, and
the light-blue circle represents the CD8a2 subunit.November 2020 | Volume 11 | Article 605085
Liu et al. Chicken CD8/pMHC I Complexthe antibody-like binding mode of the known human and mouse
CD8/pMHC-I complexes (19, 35–37). The results showed the
heterogeneity of the CTL population and the diversity of its
binding with pMHC-I.
ComplexB shares the sameantibody-likebindingmodewith the
known CD8/pMHC-I complexes in mammals, of which the
protruding CD loop was clamped by the CDR loops of cCD8a. It
has been proven that CD8 and TCR cooperatively bind pMHC-I
and enhance peptide discrimination (57). The stalk regions of CD8
are interpreted to be highly flexible, but O-glycosylation may
significantly restrict the flexibility of the stalks and the mobility of
the CD8 head group relative to the T cell membrane (58–60).
Therefore, “face-to-face” binding causes the cCD8aa binding
orientation to pBF2*1501 and pBF2*0401 to skew towards the a2
domain and b2m, whichmight facilitate larger numbers of gd TCR
to bind diverse peptides presented by limited BF2 alleles in chicken.
No structures of chicken TCR-pMHC-I or TCR-pMHC-I-CD8 are
yet available in chickens, but the geometry of the TCR-pMHC-I-
CD8 complex could modulate TCR signaling and thereby directly
impact T cell development and T cell activity.
Moreover, the “face-to-face” binding mode leads to the loss of
most hydrogen bonds and salt bridges between the CD loop of
BF2*1501 and BF2*0401 and cCD8aa. However, more water
molecules contribute to the interaction between the CD loop of
BF2*1501 and BF2*0401 and cCD8aa in complex A. Importantly,
the MHC-I a3 CD loop (residues 220-228) has been proven to be
key for the CD8aa-pMHC-I interaction (43, 56). So, these distinct
interactions between the CD loop and cCD8aamight result in the
different affinity of CD8-pMHC-I interaction in two binding
model. Several studies have demonstrated that CD8 can affect
the TCR-pMHC-I interaction that determines the consequences of
Ag engagement (61–66). Increasing the strength of the CD8-
pMHC-I interaction could substantially increase the number of
recognized peptides (67). The CD8-pMHC-I interaction strength
can optimize the degree of cross-reactivity and Ag sensitivity of
CD8 T cells at various stages of their development, and this
coreceptor recognition system has coevolved to provide an
unparalleled solution to the unique challenges of effective T cell
immunity and is necessary to regulate the balance between
optimal cross-reactivity and cognate Ag specificity (14).
Moreover, it has been reported that O-glycan sialylation of CD8
modulates the affinity for pMHC-I complex binding with little or
no effect on the overall structure of CD8 (59, 68). Thus, the
antibody-like binding and “face-to-face” binding modes coexist in
equilibrium, which might be a “clever” and important strategy that
plays an important role in Ag recognition and T cell cross-
reactivity during peripheral antigen recognition.
In conclusion, the coexistence of two binding modes in
chicken CD8/pMHC-I complexes would be a result of theFrontiers in Immunology | www.frontiersin.org 12molecular arms race between pathogens and chickens, which
might enhance the T cell response to major or emerging
pathogens, including chicken-derived pathogens that are
relevant to human health. This phenomenon might be relevant
to the special chicken CTL immune response, especially for the
high proportion of approximately 50% of CD8+gdT cells in
peripheral T cells. It is worth emphasizing that chicken
CD8aa binding pMHC-I in complex A also provides a new
reference model for human T cell therapy.DATA AVAILABILITY STATEMENT
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